Search Within

Joshua Drago

Formats
  1. Meeting Abstract (13)
  2. Journal Article (9)
  3. Editorial (4)
  4. Review (4)
  5. Conference Paper (1)
Groups
  1. Breast Medicine Service (31)
  2. CTCR Scholars (31)
  3. Department of Medicine (31)
  4. MSK Grad Students (31)
  5. Master of Science in Clinical and Translational Cancer Research (31)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Sarat Chandarlapaty (17)
  2. Shanu Modi (16)
  3. Pedram Razavi (13)
  4. Mark Robson (9)
  5. Komal Jhaveri (8)
  6. Fresia Pareja Zea (7)

More People

Years
  1. 2025 (5)
  2. 2024 (7)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Research (4)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (2)
  5. Cancer Discovery (2)
  6. Nature Reviews Clinical Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (9)
  3. Nature Publishing Group (4)
  4. Oxford University Press (3)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Unlocking the potential of antibody - Drug conjugates for cancer therapy
    Review

    Drago, J. Z.; Modi, S.; Chandarlapaty, S.
    Nature Reviews Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Tailoring therapy to be just right in HER2-positive early-stage breast cancer: The Goldilocks problem
    Editorial

    Drago, J. Z.; Jhaveri, K.
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Inferences about drug safety in phase III trials in oncology: Examples from advanced prostate cancer
    Journal Article

    Drago, J. Z.; Gönen, M.; Thanarajasingam, G.; Sacks, C. A.; Morris, M. J.; Kantoff, P. W.; Stopsack, K. H.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Massively parallel sequencing analysis of microsatellite instability in breast cancer
    Meeting Abstract

    Selenica, P.; Pareja, F.; Ferrando, L.; Brown, D. N.; Riaz, N.; Weigelt, B.; Drago, J. Z.; Robson, M. E.; Razavi, P.; Chandarlapaty, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of breast cancer in African American women
    Meeting Abstract

    Serna-Tamayo, C.; Drago, J. Z.; Dos Anjos, C.; Herbert, J.; Pareja, F.; Modi, S.; Jhaveri, K.; Dang, C.; Solit, D. B.; Norton, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic profiling of primary and metastatic breast cancer in men
    Meeting Abstract

    Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Adverse event profiles of apalutamide, enzalutamide, and darolutamide in SPARTAN, PROSPER, and ARAMIS: How confident are we about which drug is safest?
    Meeting Abstract

    Drago, J. Z.; Kantoff, P. W.; Stopsack, K. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • FGFR1 amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor-positive (HR(+)) breast cancer
    Journal Article

    Drago, J. Z.; Formisano, L.; Juric, D.; Niemierko, A.; Servetto, A.; Wander, S. A.; Spring, L. M.; Vidula, N.; Younger, J.; Peppercorn, J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Detection of subthreshold microsatellite instability in breast cancer: An ongoing investigation
    Meeting Abstract

    Drago, J. Z.; Latham, A.; Modi, S.; Razavi, P.; Stadler, Z. K.; Robson, M. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save